Serial 90160274
Live / Registered — Registered (as of 28 Nov 2023)
What this means for you
Registered since 28 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90160274
- Registration number
- 7231171
- Mark type
- Design / logo
- Filed
- 04 Sept 2020
- Published for opposition
- 16 Feb 2021
- Registered
- 28 Nov 2023
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Owner
- Kyverna Therapeutics, Inc., Emeryville, CA, US
- Kyverna Therapeutics, Inc., Emeryville, CA, US
- Kyverna Therapeutics, Inc., Berkeley, CA, US
Prosecution history
- 28 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 27 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Sept 2023 — USE AMENDMENT FILED
- 04 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Sept 2023 — TEAS STATEMENT OF USE RECEIVED
- 22 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2023 — SOU EXTENSION 4 GRANTED
- 20 Mar 2023 — SOU EXTENSION 4 FILED
- 20 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2022 — SOU EXTENSION 3 GRANTED
- 19 Aug 2022 — SOU EXTENSION 3 FILED